Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg

Showing results (611-620 of 633) with videos related to

Pageof 64
Sort By:
Gastroenterology|April 29, 2014
Genome-wide association study identifies variants associated with autoimmune hepatitis type 1Ynto S de Boer, Nicole M F van Gerven, Antonie Zwiers, et al.
Nature Genetics|October 21, 2015
A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosisStephan Buch, Felix Stickel, Eric Trépo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 9, 2021
Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis BHeejoon Jang, Jun Sik Yoon, Soo Young Park, et al.
Journal of Hepatology|October 4, 2021
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis BHwi Young Kim, Pietro Lampertico, Joon Yeul Nam, et al.
JHEP Reports : Innovation in Hepatology|April 7, 2023
Treating hepatitis D with bulevirtide - Real-world experience from 114 patientsChristopher Dietz-Fricke, Frank Tacke, Caroline Zöllner, et al.
Hepatology (Baltimore, Md.)|October 21, 2019
Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol MisusersFelix Stickel, Philipp Lutz, Stephan Buch, et al.
Hepatology (Baltimore, Md.)|August 4, 2023
A global action agenda for turning the tide on fatty liver diseaseJeffrey V Lazarus, Henry E Mark, Alina M Allen, et al.
Gut|February 14, 2023
Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)Emmanuel Weiss, Carlos de la Peña-Ramirez, Ferran Aguilar, et al.
Journal of Hepatology|June 23, 2023
A global research priority agenda to advance public health responses to fatty liver diseaseJeffrey V Lazarus, Henry E Mark, Alina M Allen, et al.
Lancet (London, England)|May 2, 2026
Implementing sustainable liver health in Europe: a second EASL-Lancet CommissionTom H Karlsen, Sharon J Hutchinson, Shira Zelber-Sagi, et al.
Pageof 64

Showing results (611-620 of 633) with videos related to

Sort By:
Pageof 64
Gastroenterology|April 29, 2014
Genome-wide association study identifies variants associated with autoimmune hepatitis type 1Ynto S de Boer, Nicole M F van Gerven, Antonie Zwiers, et al.
Nature Genetics|October 21, 2015
A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosisStephan Buch, Felix Stickel, Eric Trépo, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 9, 2021
Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis BHeejoon Jang, Jun Sik Yoon, Soo Young Park, et al.
Journal of Hepatology|October 4, 2021
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis BHwi Young Kim, Pietro Lampertico, Joon Yeul Nam, et al.
JHEP Reports : Innovation in Hepatology|April 7, 2023
Treating hepatitis D with bulevirtide - Real-world experience from 114 patientsChristopher Dietz-Fricke, Frank Tacke, Caroline Zöllner, et al.
Hepatology (Baltimore, Md.)|October 21, 2019
Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol MisusersFelix Stickel, Philipp Lutz, Stephan Buch, et al.
Hepatology (Baltimore, Md.)|August 4, 2023
A global action agenda for turning the tide on fatty liver diseaseJeffrey V Lazarus, Henry E Mark, Alina M Allen, et al.
Gut|February 14, 2023
Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)Emmanuel Weiss, Carlos de la Peña-Ramirez, Ferran Aguilar, et al.
Journal of Hepatology|June 23, 2023
A global research priority agenda to advance public health responses to fatty liver diseaseJeffrey V Lazarus, Henry E Mark, Alina M Allen, et al.
Lancet (London, England)|May 2, 2026
Implementing sustainable liver health in Europe: a second EASL-Lancet CommissionTom H Karlsen, Sharon J Hutchinson, Shira Zelber-Sagi, et al.
Pageof 64